样式: 排序: IF: - GO 导出 标记为已读
-
Choice of revascularization strategy for ischemic cardiomyopathy due to multi-vessel coronary disease J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-15 Anas H. Alzahrani MD MPH MD, Shinobu Itagaki MD MSc, Natalia Egorova PhD, Joanna Chikwe MD
Limited comparative data guide the decision between coronary bypass surgery (CABG) versus percutaneous coronary intervention (PCI) for multivessel revascularization in ischemic cardiomyopathy. To compare long-term outcomes of CABG and PCI for ischemic cardiomyopathy. Clinical registries from NJ Department of Health linked to administrative databases were used to compare all-cause mortality, repeat
-
Commentary: Readmission Realities in Thoracic Aortic Surgery J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-15 Derek Serna-Gallegos MD, Ibrahim Sultan MD
-
Reply: Atrial fibrillation surgery concomitant with mitral valve surgery: Much more than gilding the lily J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-15 Min-Seok Kim MD PhD, Seung Hyun Lee MD PhD
-
From information creep to indication creep J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-15 Amedeo Anselmi MD PhD, Sylvain Beurtheret MD, Fabio Barili MD PhD, Ovidio A. García-Villarreal MD, International Evidence Grading Research Initiative Targeting Transparency and Quality (INTEGRITTY)
-
Long-term Outcomes Following Valve-Sparing Root Replacement with Concomitant Mitral Repair J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-06 Maral Ouzounian MD PhD, Myriam Lafreniere-Roula PhD, Malak Elbatarny MD, Carolyn M. David RN, Jennifer CY. Chung MD MSc, Tirone E. David MD
To examine the late outcomes of valve-sparing root replacement and concomitant mitral valve repair in patients who have been followed prospectively for more than two decades. From 1992 to 2020, 54 consecutive patients (mean age 47±16 years; 80% male) underwent valve-sparing root replacement (45 reimplantation; 9 remodeling) with concomitant repair of the mitral valve. Patients were followed prospectively
-
Identifying and Mitigating Risk of Post-Cardiotomy Cardiogenic Shock in Patients with Ischemic and Non-Ischemic Cardiomyopathy J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-05 Michael J. Javorski MD MS, Karolis Bauza BMBCh DPhil, Fei Xiang MD, Edward Soltesz MD MPH, Lin Chen BA, Faisal G. Bakaeen MD, Lars Svensson MD PhD, Lucy Thuita MS, Eugene H. Blackstone MD, Michael Z. Tong MD MBA
To identify preoperative predictors of post-cardiotomy cardiogenic shock in patients with ischemic and non-ischemic cardiomyopathy and evaluate trajectory of postoperative ventricular function. From 1/2017–1/2020, 238 patients with ejection fraction <30% (206/238) or 30-34% with at least moderately severe mitral regurgitation (32/238) underwent conventional cardiac surgery at Cleveland Clinic, 125
-
Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-05 Hilmi Alnsasra MD, Radha Kanneganti Perue MD, Fouad Khalil MD, Ohad Regev MD, Sudhir S. Kushwaha MD, Alexandros Briasoulis MD PhD, Rabea Asleh MD PhD MHA
In light of the updated lowered threshold for diagnosing pulmonary hypertension (PH), the reversibility of precapillary PH with left ventricular assist device (LVAD) and the associated post heart transplantation (HT) outcomes remain unclear. Using data from the United Network for Organ Sharing database, we aimed to investigate predictors of persistent precapillary PH in HT recipients bridged with LVAD
-
Percent predicted peak oxygen uptake is superior to weight-indexed peak oxygen uptake in risk stratification before lung cancer lobectomy J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-05 Karolina Kristenson MD PhD, Kristofer Hedman MD PhD
To improve preoperative risk stratification in lung cancer lobectomy by identifying and comparing optimal thresholds for peak oxygen uptake (VO) presented as weight-indexed and percent of predicted values, respectively. Longitudinal cohort study including national registry data, on patients scheduled for cancer lobectomy, using available data from preoperative cardiopulmonary exercise testing. The
-
Surgical Resection of Benign Primary Cardiac Tumors: a Six-Decade Evaluation of Survival and Recurrence J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-04 Annalisa Bernabei MD, Andrew J. Toth MS, A. Marc Gillinov MD, Eugene H. Blackstone MD, Michael B. Komarovsky BA, Jacky H.K. Chen BS, Peter Chin BA, James C. Witten MD, Daniel J.P. Burns MD M.Phil., Patrick Collier MD PhD, Rohit Moudgil MD PhD, Eric E. Roselli MD
-
Commentary: Acute Type A Dissection with Malperfusion Syndrome, Start Your Stopwatch? J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-04 Gardner Yost MD MS, David Williams MD, Bo Yang MD PhD
-
Reply: Surgery follows mother nature J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-04 B, o, , Y, a, n, g, , M, D, , P, h, D
-
Leaflet to annulus ratio of 1.5 proves superior and easy to adopt J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-02 Marek J. Jasinski FETCS MD PhD, Jakub Jasinski MD, Andrzej Kansy MD PhD
-
Reply: Future considerations for adeno-associated viral gene therapy in ex vivo lung perfusion J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-03-01 Qimeng Gao MD MHS, Isaac S. Alderete BS, Benjamin Hughes PhD, Matthew G. Hartwig MD MHS
-
Gene delivery in a rodent lung transplant model J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-15 Michael G. Katz, Efrat Eliyahu, Kiyotake Ishikawa
-
Ventricular Assist Device using a Thoracotomybased Implant Technique: Multi-center HeartMate 3 SWIFT Study J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-15 Igor Gosev, Duc Thinh Pham, John Y. Um, Anelechi C. Anyanwu, Akinobu Itoh, Kunal Kotkar, Koji Takeda, Yoshifumi Naka, Matthias Peltz, Scott C. Silvestry, Gregory Couper, Marzia Leacche, Vivek Rao, Benjamin Sun, Ryan J. Tedford, Nahush Mokadam, Robert McNutt, Daniel Crandall, Mandeep R. Mehra, Christopher T. Salerno
The HeartMate 3 (HM3) left ventricular assist device (LVAD) provides substantial improvement in long-term morbidity and mortality in advanced heart failure patients. The SWIFT study compares thoracotomy-based implantation clinical outcomes with standard median sternotomy. We conducted a prospective, multicenter, single-arm study in patients eligible for HM3 implantation with thoracotomy-based surgical
-
Reply: Interpretation of subgroup analyses J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-13 Edward L. Hannan, Lamia Harik, Mario Gaudino
-
2023 Reviewers for The Journal of Thoracic and Cardiovascular Surgery J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-13
-
-
-
Induction therapy for non–small cell lung cancer J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-12 Alissa Cooper MD, Jamie E. Chaft MD, Matthew J. Bott MD
-
-
-
-
-
-
-
-
-
Optimal timing of Ross operation in children: A moving target? J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-11 Igor E. Konstantinov MD PhD FRACS, Emile Bacha MD, David Barron MD FRCS, Tirone David MD, Joseph Dearani MD, Yves d’Udekem MD PhD FRACS, Ismail El-Hamamsy MD PhD, Hani K. Najm MD MSc, Pedro J. del Nido MD, Christian Pizarro MD, Peter Skillington MBBS FRACS, Vaughn A. Starnes MD, David Winlaw MBBS FRACS
-
Utility of structured follow-up imaging after aortic surgery J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-10 Megan M. Chung BA, Annie Yu ANP, Yanling Zhao MS, Elizabeth Wist MS PA-C, Yu Hohri MD PhD, Paul Kurlansky MD, Jay Leb MD, Thomas F.X. O’Donnell MD, Virendra Patel MD MPH, Hiroo Takayama MD PhD
Although postoperative follow-up after aortic surgery is recommended by guidelines, its clinical utility is not well documented. We hypothesized that structured follow-up imaging by an aortic program would improve outcomes. We then documented radiologic findings on asymptomatic postoperative imaging. All patients who survived to discharge after open thoracic aortic surgery between January 2017 and
-
Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-10 Zhenlin Yang MD, Shuaibo Wang MD, Haitang Yang MD, Yina Jiang MD, Linhai Zhu MD, Bin Zheng MD, Honghao Fu MD, Junliang Ma MD, Hounai Xie MD, Zhiqiang Wang MD, Huayu He MD, Chuanbao Xia MD, Renda Li MD, Jiachen Xu MD, Jiefei Han MD, Xuhua Huang MD, Yixing Li MD, Baicheng Zhao MD, Chenhui Ni MD, Huajie Xing MD, Yangtian Chen MD, Jingdi Wang MD, Yuequan Jiang MD, Yongxiang Song MD, Yousheng Mao MD, Chun
Neoadjuvant immunotherapy has ushered in a new era of perioperative treatment for resectable non–small cell lung cancer (NSCLC). However, large-scale data for verifying the efficacy and optimizing the therapeutic strategies of neoadjuvant immunochemotherapy in routine clinical practice are scarce. NeoR-World (NCT05974007) was a multicenter, retrospective cohort study involving patients who received
-
-
Targeted versus systematic nodal staging in early-stage lung cancer J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-09 Daniël A. Korevaar, Jouke T. Annema
-
Complication Rates Rise with Age and Haller Index in Minimal Invasive Correction of Pectus Excavatum: A High-volume Single-centre Retrospective Cohort Study J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-09 Ara S. Media, Thomas Decker Christensen, Niels Katballe, Peter Juhl-Olsen, Henrik Vad, René Horsleben Pedersen, Anette Højsgaard, Frank Vincenzo de Paoli
Describing the Compounded Complication Rate (CCR) of MinimaI invasive Repair of Pectus Excavatum (MIRPE), identifying predisposing risk factors, and evaluating the optimal timing of correction. MIRPE is standard PE treatment and consists of two invasive procedures e.g., correction with bar insertion followed by bar removal after 2-3 years. A retrospective cohort study identifying children, adolescents
-
Discussion to: Outcomes of neoaortic valve and root surgery late after arterial switch operation J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-09
-
Impact of Telehealth Post-operative Care on Early Outcomes Following Esophagectomy J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-09 Karren Xiao, Jarlath Bolger, Frances Allison, Gail E. Darling, Jonathan C. Yeung
This study aimed to address the short-term clinical outcomes of post-esophagectomy patients who underwent telehealth care following surgery. The primary objective was to compare the frequency of emergency department admission between telehealth and in-person cohorts. Secondary objectives included comparing the frequency of endoscopies and clinic visits, as well as reasons for emergency department admission
-
What are the conotruncal malformations? J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-07 Robert H. Anderson, Timothy J. Mohun, Deborah J. Henderson
-
What drives variability in postoperative cardiac surgery transfusion rates? J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-07 Carrinton Mauney BS, Eric Etchill MD MPH, Amanda Rea MSN CRNP, Clifford Edwin Fonner BS, Glenn Whitman MD, Rawn Salenger MD
Wide interhospital variation exists in cardiac surgical postoperative transfusion rates. We aimed to compare transfusion rates at 2 hospitals and identify the institutional practice factors, unrelated to patient or operative characteristics, associated with postoperative transfusion rates. Records for adult patients undergoing routine cardiac surgery at 2 hospitals (H and L) from February 2020 to August
-
Y-incision aortic annular enlargement and the golden ratio: Nature leads the way J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-07 Dimitrios E. Magouliotis, Andrew Xanthopoulos, Thanos Athanasiou
-
Outcomes of aortic surgery in patients with Takayasu arteritis J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-06 Defne Gunes Ergi MD, Hartzell V. Schaff MD, Alberto Pochettino MD, Philip D. Hurst MD, Kevin L. Greason MD, Richard C. Daly MD, Juan A. Crestanello MD, Joseph A. Dearani MD, Austin Todd MS, Nishant Saran MD MBBS
-
Discussion to: The majority of pediatric Fontan patients have excellent posttransplant survival J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-06
Abstract not available
-
Four Decades of Progress in Heart-Lung Transplantation: 271 Cases at a Single Institution. J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-05 Stefan Elde, Basil M. Baccouche, Danielle M. Mullis, Matthew M. Leipzig, Tobias Deuse, Aravind Krishnan, Moeed Fawad, Reid Dale, Sabrina Walsh, Amanda Padilla-Lopez, Brandon Wesley, Hao He, Shin Yajima, Yuanjia Zhu, Hanjay Wang, Brandon A. Guenthart, Yasuhiro Shudo, Bruce A. Reitz, Y. Joseph Woo
The objective of this study is to evaluate survival for combined heart-lung transplant (HLTx) recipients across four decades at a single institution. We aim to summarize our contemporary practice based upon more than 271 HLTx over 40 years. Data were collected from a departmental database and the United Network for Organ Sharing (UNOS). Recipients <18y, those undergoing redo HLTx , or triple-organ
-
Video-assisted mediastinoscopic lymphadenectomy (VAMLA): mature results for staging non-small cell lung cancer with normal mediastinum J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-03 Sergi Call, Nina Reig-Oussedik, Carme Obiols, José Sanz-Santos, Juan Manuel Ochoa-Alba, Lucía Reyes Cabanillas, Mireia Serra-Mitjans, Ramón Rami-Porta
-
Commentary: Challenging the assumptions of body mass index and mortality in use of extracorporeal membrane oxygenation for adult respiratory distress syndrome J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-03 Tessa M.F. Watt MD, Ranjit John MD
Abstract not available
-
Importance of reporting mortality and morbidity following thoracoabdominal aortic aneurysm repair according to the Crawford classification J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-02 Nicholas T. Kouchoukos
Abstract not available
-
Coronary artery bypass grafting is superior to percutaneous coronary intervention for all women subgroups J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-02 Victor Dayan, Nick Freemantle, Stefano Urso, Rafael Sadaba
Abstract not available
-
Book Review of Nobility in small things: A surgeon’s path J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-02 G. Alexander Patterson
Abstract not available
-
Unplanned readmissions, community socioeconomic factors, and their effects on long-term survival after complex thoracic aortic surgery J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-02-01 Ourania Preventza, Jaymie Henry, Lubna Khan, Lorraine D. Cornwell, Katherine H. Simpson, Subhasis Chatterjee, Hiruni S. Amarasekara, Marc R. Moon, Joseph S. Coselli
-
Discussion to: National enrollment of lung cancer clinical trials is disproportionate based on race and health care access J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-28
Abstract not available
-
Completion of Accrual for TSOG 102—One Small Step Forward for Thoracic Clinical Trials J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-29 James Huang, David R. Jones
Abstract not available
-
Discussion to: Bicuspid aortic stenosis: National three-year outcomes of transcatheter versus surgical aortic valve replacement among Medicare beneficiaries J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-28
Abstract not available
-
The American Association for Thoracic Surgery 2023 Expert Consensus Document: Recommendation for the care of children with trisomy 13 or trisomy 18 and a congenital heart defect J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-27 James D. St Louis, Aarti Bhat, John C. Carey, Angela E. Lin, Paul C. Mann, Laura Miller Smith, Benjamin S. Wilfond, Katherine V. Kosiv, Robert A. Sorabella, Bahaaldin Alsoufi
Objectives Recommendations for surgical repair of a congenital heart defect in children with trisomy 13 or trisomy 18 remain controversial, are subject to biases, and are largely unsupported with limited empirical data. This has created significant distrust and uncertainty among parents and could potentially lead to suboptimal care for patients. A working group, representing several clinical specialties
-
Appropriate sizing of the frozen elephant trunk: How to predict proximal descending aortic diameter prior to dissection? J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-26 Yuichiro Kitada, Homare Okamura, Taketo Yamauchi, Satoshi Nishi, Mamoru Arakawa, Naoyuki Kimura, Koji Kawahito, Atsushi Yamaguchi
-
Acute Type A Intramural Hematoma: The Less Deadly Acute Aortic Syndrome? J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-25 Rana-Armaghan Ahmad, Felix Orelaru, Akul Arora, Carol Ling, Karen M. Kim, Shinichi Fukuhara, Himanshu Patel, G Michael Deeb, Bo Yang
Objective To evaluate the short- and mid-term outcomes of surgically managed acute type A intramural hematoma (IMH) versus classic acute type A aortic dissection (ATAAD). Methods From 1996-February 2023, a total of 106 acute type A IMH patients and 795 classic ATAAD patients presented for open aortic repair at our institution. Data were obtained from the local Society of Thoracic Surgeons’ Data Warehouse
-
Discussion to: Renal recovery in cardiac surgery patients requiring postoperative renal-replacement therapy J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-25
Abstract not available
-
Predictors & Outcomes of Discharge to Long-Term Acute Care Facilities after Cardiac Surgery J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-24 Haley Jenkins, Ibrahim Elkilany, Erhan Guler, Kaleigh Cummins, Kamal Ayyat, Caroline Pennacchio, Samir R. Kapadia, Fasial Bakaeen, A. Marc Gillinov, Lars G. Svensson, Haytham Elgharably
Objective An increasing number of patients with significant comorbidities present for complex cardiac surgery, with a subgroup requiring discharge to long-term acute care facilities (LTAC). We aim to examine predictors and mortality after discharge to LTAC. Methods From 1/01/2015 to 4/30/2021, all adult cardiac surgeries were queried and patients discharged to LTAC were identified. Baseline characteristics
-
Commentary: Light at the end of the dialysis tunnel- Renal recovery after cardiac surgery J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-24 Prakash Jayanthi, Subhasis Chatterjee
Abstract not available
-
Truncal Valve Surgery during Repair of Truncus Arteriosus and Interrupted Aortic Arch J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-23 Aybala Tongut, Mahmut Ozturk, Manan Desai, Sofia Hanabergh, Can Yerebakan, Yves d’Udekem
Truncal valve regurgitation and interrupted aortic arch increase the need for reintervention and mortality rates in neonates undergoing truncus arteriosus repair. This featured case report presents a surgical video demonstrating the tricuspidization of a quadricuspid truncal valve during repair of truncus arteriosus and interrupted aortic arch in a 9-day-old girl. The patient had a quadricuspid and
-
Aortic insufficiency following balloon aortic valvuloplasty does not impact long-term autograft durability after the Ross procedure J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-22 Sameer Singh, Ismail Bouhout, Stephanie Nguyen, Alice Vinogradsky, Anna Lampe, Morgan Moroi, Michael Salna, Hiroo Takayama, Emile Bacha, Andrew B. Goldstone
-
The risk and reward of surgical aortic valve replacement J. Thorac. Cardiovasc. Surg. (IF 6.0) Pub Date : 2024-01-24 J, o, s, e, p, h, , E, ., , B, a, v, a, r, i, a, , M, D
Abstract not available